CarrierGene Biotech (Suzhou) Co.
Latest round
- Series B
Last raised
- Jun 2022
Total raised
- $92M
Investors
- 15
About CarrierGene Biotech (Suzhou) Co.
, Ltd is a gene detection company that focuses on genetic screening and diagnosis through genetic technology and big data algorithms, providing genetic data analysis and health management recommendations. The company has offices in Houston, Shanghai and Suzhou. The company passed ISO9001 and ISO13485 quality management system certification. The clinical product line of CarrierGene Biotech is mainly in the field of oncology and reproductive health. The company's core technologies include BDA, Toehold and QASeq. BDA technology can selectively amplify mutations in a wild-type DNA background to the extent that it can be applied to liquid tumor biopsies. Toehold technology is widely used in oncology precision medicine, pathogenic microbial detection and other applications such as the construction of molecular motors, logic gates and other nanodevices, as well as in the study of signal amplification in biosensors., MD Anderson and Yale University and other enterprises. The company will develop new genetic testing products and drive registration approval for clinical products and expand its commercial teams in China and the United States. The company will also focus on nucleic acid detection underlying technology development.
Who invested in CarrierGene Biotech (Suzhou) Co.
15 investors across 3 rounds
See all investors in CarrierGene Biotech (Suzhou) Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CarrierGene Biotech (Suzhou) Co.
Who invested in CarrierGene Biotech (Suzhou) Co.?
CarrierGene Biotech (Suzhou) Co. has 15 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CarrierGene Biotech (Suzhou) Co. raised?
CarrierGene Biotech (Suzhou) Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did CarrierGene Biotech (Suzhou) Co. last raise money?
CarrierGene Biotech (Suzhou) Co.'s most recent round on record is a Series B, in Jun 2022.
What does CarrierGene Biotech (Suzhou) Co. do?
, Ltd is a gene detection company that focuses on genetic screening and diagnosis through genetic technology and big data algorithms, providing genetic data analysis and health management recommendations.
Where is CarrierGene Biotech (Suzhou) Co. headquartered?
CarrierGene Biotech (Suzhou) Co. is headquartered in Suzhou, China.
Which VCs invest in companies like CarrierGene Biotech (Suzhou) Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at CarrierGene Biotech (Suzhou) Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like CarrierGene Biotech (Suzhou) Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.